Evidence map›Paper›PMID 40002698›Full record

ReviewBiomedicines2025

A Future Picture: A Review of Current Generative Adversarial Neural Networks in Vitreoretinal Pathologies and Their Future Potentials.

Raheem Remtulla, Adam Samet, Merve Kulbay, Arjin Akdag, Adam Hocini, Anton Volniansky, Shigufa Kahn Ali, Cynthia X Qian

Abstract readReview
In one paragraph

Review in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Raheem RemtullaDepartment of Ophthalmology & Visual Sciences, McGill University, Montreal, QC H4A 3SE, Canada.
Adam SametDepartment of Ophthalmology & Visual Sciences, McGill University, Montreal, QC H4A 3SE, Canada.
Merve KulbayDepartment of Ophthalmology & Visual Sciences, McGill University, Montreal, QC H4A 3SE, Canada.ORCID 0000-0003-2756-3973
Arjin AkdagFaculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.
Adam HociniFaculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.ORCID 0009-0004-4096-7037
Anton VolnianskyDepartment of Psychiatry, Université Laval, Quebec City, QC G1V 0A6, Canada.
Shigufa Kahn AliCentre de Recherche de l'Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC H1T 2M4, Canada.
Cynthia X QianCentre de Recherche de l'Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC H1T 2M4, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Machine learning has transformed ophthalmology, particularly in predictive and discriminatory models for vitreoretinal pathologies. However, generative modeling, especially generative adversarial networks (GANs), remains underexplored. GANs consist of two neural networks-the generator and discriminator-that work in opposition to synthesize highly realistic images. These synthetic images can enhance diagnostic accuracy, expand the capabilities of imaging technologies, and predict treatment responses. GANs have already been applied to fundus imaging, optical coherence tomography (OCT), and fluorescein autofluorescence (FA). Despite their potential, GANs face challenges in reliability and accuracy. This review explores GAN architecture, their advantages over other deep learning models, and their clinical applications in retinal disease diagnosis and treatment monitoring. Furthermore, we discuss the limitations of current GAN models and propose novel applications combining GANs with OCT, OCT-angiography, fluorescein angiography, fundus imaging, electroretinograms, visual fields, and indocyanine green angiography.

Indexed as

computer visiondiagnostic imaginggenerative adversarial neural networkspredictive modelingvitreoretinal pathology

Identifiers

PMID40002698
PMCPMC11852121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.